Sofosbuvir as Repurposed Antiviral Drug Against COVID-19: Why Were We Convinced to Evaluate the Drug in a Registered/Approved Clinical Trial?
2020 · Archives of Medical Research · 80 citations
https://doi.org/10.1016/j.arcmed.2020.04.018
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
11
Papers
131
Citations
5
h-index
3
i10-index
Reza Khodarahmi is an academic researcher from Kharazmi University. The author has contributed to research in topics: COVID-19 Clinical Research Studies & SARS-CoV-2 and COVID-19 Research & Hepatitis C virus research. The author has an h-index of 5, co-authored 10 publications.
https://doi.org/10.1016/j.arcmed.2020.04.018
https://doi.org/10.1093/jac/dkab152
Click to start Chat